Skip to main content

Phenazopyridine Hydrochloride for Dysuria

INDICATIONS AND USAGE: 

Phenazopyridine (Pyridium) is indicated for the symptomatic relief of burning, pain, urgency, frequency and other conditions arising from irritation of the lower urinary tract mucosa caused by infection, trauma, surgery, endoscopic procedures, or the passage of sounds or catheters.

The use of Phenazopyridine Hydrochloride for relief of symptoms should not delay definitive diagnosis and treatment of causative conditions. Because it provides only symptomatic relief, prompt appropriate treatment of the cause of pain must be instituted and Phenazopyridine Hydrochloride should be discontinued when symptoms are controlled.

CONTRAINDICATIONS: Phenazopyridine Hydrochloride should not be used in patients who have previously exhibited allergy to it. The use of Phenazopyridine Hydrochloride is contraindicated in patients with renal insufficiency.

Information for Patients: Phenazopyridine Hydrochloride produces an orange to red color in the urine and may stain clothes. Staining of contact lenses has been reported.

ADVERSE REACTIONS:

Headache, rash, pruritus and occasional gastrointestinal disturbance. An anaphylactoidlike reaction has been described. Methemoglobinemia, hemolytic anemia, renal and hepatic toxicity have been reported, usually at overdose levels 

DOSAGE and ADMINISTRATION:
100 mg tablets: Adult dosage is two tablets 3 times a day after meals. 
200 mg tablets: Adult dosage is one tablet 3 times a day after meals.  

  •  should not be used more than 2 days when used concomitantly with an antibiotic



References: 
1. http://www.shijiebiaopin.net/upload/product/201122300005125.pdf
2. Product Information: PYRIDIUM(R) oral tablet, phenazopyridine hydrochloride oral tablet. Warner Chilcott, Inc, Rockaway, NJ, 2002.

Comments

  1. Arabian ExpertJuly 9, 2021 at 10:49 PM

    After a long time, I read a very beautiful and very important article that I enjoyed reading. I have found that this article has many important points, I sincerely thank the admin of this website for sharing it. Best شبكة vpn مجانية service provider.

    ReplyDelete

Post a Comment

Popular posts from this blog

Mounjaro, Is it a game changer for weight loss and diabetes?

  MOUNJARO™ ( Tirzepatide) was approved for medical use in the United States in May 2022 WEIGHT LOSS: (Not approved by FDA for weight loss) Eli Lilly and Company is  finalizing an application to the U.S. Food and Drug Administration for fast-track approval to sell tirzepatide for chronic weight management. MOUNJARO™ is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated in adults for type 2 diabetes mellitus management. CONTRAINDICATIONS Personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2  Known serious all to tirzepatide or any of the excipients in MOUNJARO                                                                    ...
Post a Comment
Read more

Thyroid health- Quality of Life

  Let's get a TSH blood test for our family and friends Normal serum TSH ranges are higher in the  people age 70 to 80 years ; based on this, higher serum TSH goals may be needed as a patient ages.  The American Thyroid Association (ATA) suggests raising the target serum TSH to 4-6 m IU/L for 70 years-old and up The thyroid is a small, butterfly-shaped hormone-producing gland located at the front of the neck. The thyroid gland secretes two main hormones:  thyroxine (T-4) and triiodothyronine (T-3).   These hormones regulate energy levels, metabolism of fats, proteins and carbohydrates, body temperature, heart rate.  Hypothyroidism happens when the underactive thyroid gland doesn't make enough hormones. Hypothyroidism affects up to 10% of the general population (5% undiagnosed) . A n autoimmune disease called Hashimoto's diseas e where our body  makes antibodies that attack healthy thyroid tissues  is the most common cause of hypothyroidism in soc...
Post a Comment
Read more

Vaccines, XBB.1.5 variant and antibody evasion

Corona virus XBB and XBB.1 were first identified in India in mid-August and quickly became predominant in India.  The spike protein of the predominant XBB subvariant has 14 mutations in addition to those found in BA.2, including 5 in the N-terminal domain (NTD) and 9 in the receptor-binding domain (RBD), whereas XBB.1 has an additional G252V mutation. Single and combination therapies with monoclonal antibodies have received emergency use authorization for COVID-19.  Using  COVID-19 pseudovirus, which enables the study of the SARS-CoV-2 virus in cell culture,   XBB, and XBB.1 subvariants were found to have far greater antibody resistance than earlier variants. XBB sublineages are completely resistant to bebtelovimab, leaving us with no authorized antibody for treatment use. The combination of mAbs known as Evusheld that is authorized for the prevention of COVID-19 is also completely inactive against the new subvariants. This poses a serious problem for millions of im...
Post a Comment
Read more